Novantrone (mitoxantrone) FDA- approved for MS
- Details
- Category: Medications
- Written by R. Adam Quigley
- Hits: 1465
* powerful immunosuppressive medication - rarely used
* chemotherapy agent
* for secondary prgoressive, progressive relapsing, and some
types of relapsing-remitting MS
* reduces relapses and lengthens time between relapses
* IV infusion once every three months
* side effects: risk of heart muscle injury (5%) and leukemia (1%)
* nausea, hair loss, menstrual disorders (permanent menopause)
* improvement compared to other treatments
* approved in 2000



Ultrahigh-field strength, T1-weighted magnetization-prepared rapid acquisition and multiple gradient echoes (MPRAGE) is highly sensitive for detecting multiple sclerosis (MS) plaques within the white and gray brain parenchyma, according to a study published online Feb. 20 in Archives of Neurology, one of the JAMA/Archives...
Cannabis-based medicinal products, such as Sativex, could soon be available to sufferers of Multiple Sclerosis (MS) and other medical conditions on prescription.
One in a lakh Indians is thought to suffer from multiple sclerosis, a life-long disorder of the nervous system. Support groups are lobbying to bring the disease under the Disability Act, and are fighting for insurance cover.



